『2 Minutes with Joey - JNJ Stock News』のカバーアート

2 Minutes with Joey - JNJ Stock News

2 Minutes with Joey - JNJ Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on Johnson & Johnson (JNJ) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • JNJ Today - Aug 13: Tiny Move, Big Questions

    JNJ Today - Aug 13: Tiny Move, Big Questions
    2026/08/13
    Hey there! I'm Joey, a longtime investor just breaking down how Johnson & Johnson did today. So, JNJ had a pretty chill day. It barely moved, just up a tiny bit—like, 0.04%. Not exactly fireworks, right?

    So, what happened? Honestly, not much. The stock just kind of floated around. Volume was right on average, so no big rush in either direction. It seems like everyone’s just waiting to see what’s next.

    Now, why is that? Well, a couple of things are buzzing around. There’s some chatter about JNJ hitting that massive $100 billion revenue mark soon. That's a big deal! But then there’s also talk about some firms selling off shares, like Guardian Investment Management unloading almost 9,000 shares. That kind of stuff can make people a bit jittery. Plus, there's a comparison with AbbVie floating around, where people are weighing JNJ's safe dividend against AbbVie’s higher yield. It’s like a stock showdown, and folks are trying to figure out which is the better bet.

    Oh, and JNJ is creeping up to a 52-week high. So, that’s got some folks curious—are we in for a climb, or is it just a tease?

    Just a little heads up: some firms are boosting their stakes in JNJ, which might mean they see something good coming down the line.

    So, yeah, that’s the scoop for today. A lot of uncertainty, but that’s stock life for ya! Remember, this is just info to keep you in the loop, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • JNJ Today - Aug 12: Stock Stays Flat Amid Buzz

    JNJ Today - Aug 12: Stock Stays Flat Amid Buzz
    2026/08/12
    Hey there! It’s Joey here, your friendly longtime investor breaking down the day for you. Today, we’re talking about Johnson & Johnson, and it was kind of a flat day for the stock. It barely moved, just a slight dip of 0.07%. Not much to write home about!

    So, what went down? JNJ opened up and then just sorta hung around. No big swings, no crazy drama. It’s like that friend who shows up to the party but just stands by the snack table. The volume was right on point with its average, so people were trading like usual, but nobody was making any wild moves.

    Now, why did JNJ stay so chill? Well, there’s a lot of chatter about the company hitting that massive $100 billion revenue mark soon, which is super exciting! But with all that buzz, folks are still debating whether the stock is worth grabbing right now. Some articles even mention it's nearing a 52-week high, which can make investors think twice before diving in. Plus, there’s news about JNJ advancing its Seltorexant treatment for major depressive disorder, which is a big deal. But again, no one really knows what that means for the stock today.

    One thing worth noting is that Annex Advisory Services sold over 5,000 shares. That’s a decent chunk, and it could make some investors raise an eyebrow. It’s always interesting when you see big players making moves.

    So, yeah, the stock kinda just sat there today. JNJ’s got some exciting stuff on the horizon, but today was just a slow bleed. As always, just remember this is all for fun and info, not advice. Catch you later!
    続きを読む 一部表示
    1 分
  • JNJ Today - Aug 11: Insider Selling Sparks Concern

    JNJ Today - Aug 11: Insider Selling Sparks Concern
    2026/08/11
    Hey there! It's Joey, your friendly investor buddy, and I've been around the block a few times when it comes to stocks. Today, we're talking about Johnson & Johnson, and it was a bit of a red day, dropping by about three-quarters of a percent.

    So, what happened? Well, JNJ got smoked a little, losing a couple bucks off its price. Not a huge move, but enough to catch some eyes. The trading volume was right on average, so it wasn't like everyone was panicking or anything.

    Now, let’s chat about why it dropped. There’s been some buzz lately about insider selling. Yeah, that one stung. When insiders sell their shares, it can make people wonder if they know something we don’t. Plus, there's chatter about JNJ’s position compared to other healthcare stocks, like Medtronic. Some analysts are weighing in on which stock is better post-earnings, and that can shake things up.

    There’s also a healthcare conference coming up on September 14th where JNJ’s gonna be chatting. Investors are probably keeping an eye on that because it could give some hints about what’s next for the company.

    To wrap it up, JNJ had a tough day with some insider selling raising eyebrows and competition in the healthcare space heating up. But hey, that’s how it goes in the market! Just remember, this is all for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません